We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The agency is adding requirements for statements of compliance with FDA regulations covering human subject protection and institutional review boards. Read More
The FDA used a Q&A format to issue final guidance on an informal, non-binding process for sponsors to obtain preliminary feedback before submitting marketing applications. Read More
FDA Commissioner Scott Gottlieb offered a closer look at initiatives and investments the agency would pursue in support of novel medical technologies using new funding requested… Read More